MS250110C132000
- 0.08
- 0.000.00%
Morgan Stanley Newsroom
S&P 500 Positive for 'First Five Days,' Huang Sees Decades till Quantum | Wall Street Today
Palantir Stock Drops for 3rd Day. ARK Invest Unloads More Shares.
Wednesday Market Falls, Quantum Computing Pulls Back Hard on Treasury Yield Crunch | Live Stock
Shake Shack, Morgan Stanley, Synovus Financial And A Communication Services Stock On CNBC's 'Final Trades'
Today's Analyst Rating | UBS Upgrades Bank of America to Buy, Salesforce Price Target Raised to $400 by Needham
Morgan Stanley: Maintains "Shareholding" rating for Giant Biotechnology with a Target Price of 65 Hong Kong dollars.
Morgan Stanley released a research report stating that it expects the stock price of Gigot Biotech (02367) to rise by about 70% to 80% over the next 15 days, setting its Target Price at HKD 65 and giving it a "Shareholding" rating. The bank forecasts the company's earnings growth for the fiscal years 2024 and 2025 to be 37% and 23%, respectively, indicating that the upcoming annual performance may be stronger than that of other companies within the bank's coverage. The report mentioned that Gigot Biotech's stock price has fallen by about 12% since mid-December last year, and the bank has not yet identified a fundamental reason but believes that the relevant performance is mainly influenced by market allocation. The bank also believes that if measured by 2025.
Citigroup expects the Indian stock market to rise by 10% this year, marking the 10th consecutive year of growth.
Citigroup expects that the Indian stock market, which is valued at 5 trillion dollars, will rise for the 10th consecutive year this year, driven by economic growth recovery and strong corporate profits. Citigroup has set a target of 26,000 points for India's benchmark stock index, the Nifty 50 Index, which means the index will rise 10% compared to its closing position at the end of last year. The index is expected to close in 2024 at about 5% higher than the Wall Street bank's forecast of 22,500 points. Strategists at Citigroup, including Surendra Goyal, wrote in a report, "Considering the diversification of listed companies, India"
Morgan Stanley: Set a 'Market Perform' rating for China Tourism Group Duty Free Corporation, with the Target Price adjusted to 55 Hong Kong dollars.
Morgan Stanley released a research report stating that the Target Price for China Tourism Group Duty Free Corporation (01880) has been lowered from 60 Hong Kong dollars to 55 Hong Kong dollars, with a rating of "in line with the market." The report noted that last year, Hainan was the main factor dragging down the Chinese tourism retail market, with offline duty-free store sales dropping by 29% year-on-year to 30.9 billion RMB. Due to a lower base and the possibility of China Tourism Group offering more discounts, offline duty-free store sales in Hainan are expected to narrow their year-on-year decline to 5% by December 2024, with the impact likely diminishing by 2025. Morgan Stanley believes that the recovery of China Tourism Group's port business has already gained traction.
Tuesday Market Pulls Back After Nvidia All Time High | Wall Street Today
Express News | CNBC Halftime Report Final Trades: Shake Shack, Synovus Financial, Comcast, Morgan Stanley
Morgan Stanley Is Maintained at Buy by B of A Securities
Morgan Stanley Analyst Ratings
Market Sells CES Tech News, ISM Tuesday as Nvidia Champions Robots Monday | Live Stock
Jefferies Maintains Morgan Stanley(MS.US) With Buy Rating, Raises Target Price to $144
Express News | Eaton Vance Municipal Bond Fund Announces Extension of Tender Offer
Today's Analyst Rating | Meta Platforms Price Target Raised to $715 by Jefferies, BofA Securities Downgrades Tesla to Hold
Express News | Morgan Stanley : BofA Global Research Raises Price Objective to $146 From $140
BofA Securities Maintains Morgan Stanley(MS.US) With Buy Rating, Raises Target Price to $146
IB & Trading to Aid Jefferies' Q4 Earnings, High Costs to Hurt
Daiwa Adjusts Price Target on Morgan Stanley to $132 From $139, Maintains Neutral Rating